.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Fish and Richardson
Healthtrust
Baxter
Cipla
AstraZeneca
Mallinckrodt
Teva
Boehringer Ingelheim

Generated: December 13, 2017

DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and fifty-six approved drugs.

There are five US patents protecting HIKMA drugs on HIKMA drugs in the past three years. There are two tentative approvals on HIKMA drugs.

Summary for Hikma

US Patents:5
Tradenames:117
Ingredients:110
NDAs:156
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
HikmaCARVEDILOLcarvedilolTABLET;ORAL077887-002Sep 7, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma Intl PharmsISOSORBIDE DINITRATEisosorbide dinitrateTABLET;ORAL086066-001Oct 29, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsISOSORBIDE MONONITRATEisosorbide mononitrateTABLET;ORAL075361-001Oct 5, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaCLONIDINE HYDROCHLORIDEclonidine hydrochlorideINJECTABLE;INJECTION200300-001Jan 26, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma Intl PharmsGLYCOPYRROLATEglycopyrrolateTABLET;ORAL040836-001Mar 5, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsPIROXICAMpiroxicamCAPSULE;ORAL209256-001Aug 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaIRINOTECAN HYDROCHLORIDEirinotecan hydrochlorideINJECTABLE;INJECTION091032-001Dec 20, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaCEFOTETANcefotetan disodiumINJECTABLE;INJECTION091031-002Oct 26, 2011APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsFOLIC ACIDfolic acidTABLET;ORAL080600-001Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma FarmaceuticaCEFUROXIME SODIUMcefuroxime sodiumINJECTABLE;INJECTION065048-002Jan 9, 2004APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for HIKMA drugs

Drugname Dosage Strength Tradename Submissiondate
colchicineCapsules0.6 mgMITIGARE6/10/2016
argatroban in sodium chlorideInjection1 mg/mL, 50 mL vialsARGATROBAN12/16/2011
argatrobanInjection100 mg/mL, 2.5 mL vialsARGATROBAN9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Citi
Boehringer Ingelheim
Queensland Health
Harvard Business School
Dow
Federal Trade Commission
Merck
Teva
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot